Updated on 15 September 2026
AI peptide and protein design
Founder and CEO at Tycho
Bergamo, Italy
About
AI Peptide & Protein Design at TychoGenerative & Hallucination-Based Architectures
-
Harness state-of-the-art AI frameworks to drive de novo design of proteins, linear peptides, and cyclic macrocycles.
-
Generate novel structural scaffolds engineered specifically for difficult target binding pockets and protein-protein interfaces.
Physics-Based & Molecular Dynamics Validation
-
Integrate Molecular Dynamics (MD) simulations and free-energy profiling to validate dynamic stability and binding interactions.
-
Formulate robust binding hypotheses and structural insights to de-risk downstream wet-lab synthesis and testing.
Scaffold & Multiparameter Optimization
-
Execute targeted optimization strategies balancing affinity, selectivity, solubility, and conformational stability.
-
Bridge digital molecular design with actionable experimental testing roadmaps to accelerate hit-to-lead execution.
Similar opportunities
Service
Drug Discovery and development AI leadership
- Consulting
- Innovation management
- Research & Development
- Education, Training & Qualifying
Alberto Bresciani
Founder and CEO at Tycho
Bergamo, Italy
Expertise
Branched peptide for antiviral use
Alessandra Romeo
Knowledge Transfer Manager at Università degli Studi di Siena
Siena, Italy
Expertise
Branched peptides with antibacterial and anti-inflammatory activity
Alessandra Romeo
Knowledge Transfer Manager at Università degli Studi di Siena
Siena, Italy